Commonwealth Equity Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Commonwealth Equity Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$981K	Sell	8,285 -2,020	-20%	-$219K	﹤0.01%	2727
2026 Q1	$1.07M	Sell	10,305 -442	-4%	-$46.7K	﹤0.01%	2562
2025 Q4	$1.12M	Buy	10,747 +635	+6%	+$63.9K	﹤0.01%	2481
2025 Q3	$935K	Sell	10,112 -1,832	-15%	-$160K	﹤0.01%	2649
2025 Q2	$954K	Sell	11,944 -5,308	-31%	-$424K	﹤0.01%	2609
2025 Q1	$1.49M	Sell	17,252 -124	-0.7%	-$10.6K	﹤0.01%	2147
2024 Q4	$1.44M	Sell	17,376 -92	-0.5%	-$7.92K	﹤0.01%	2121
2024 Q3	$1.52M	Sell	17,468 -4,423	-20%	-$378K	﹤0.01%	2025
2024 Q2	$1.8M	Sell	21,891 -522	-2%	-$41.5K	﹤0.01%	1856
2024 Q1	$1.8M	Sell	22,413 -2,526	-10%	-$196K	﹤0.01%	1851
2023 Q4	$1.9M	Sell	24,939 -1,009	-4%	-$72.1K	﹤0.01%	1739
2023 Q3	$1.88M	Sell	25,948 -545	-2%	-$41.8K	﹤0.01%	1643
2023 Q2	$2M	Buy	26,493 +444	+2%	+$33.9K	﹤0.01%	1614
2023 Q1	$1.98K	Sell	26,049 -313	-1%	-$24.1K	﹤0.01%	1566
2022 Q4	$2.07M	Buy	26,362 +778	+3%	+$59.8K	0.01%	1475
2022 Q3	$1.82M	Buy	25,584 +726	+3%	+$54.1K	﹤0.01%	1481
2022 Q2	$1.86M	Sell	24,858 -1,738	-7%	-$132K	﹤0.01%	1482
2022 Q1	$2.12M	Buy	26,596 +6,110	+30%	+$474K	﹤0.01%	1469
2021 Q4	$1.66M	Sell	20,486 -1,787	-8%	-$141K	﹤0.01%	1620
2021 Q3	$1.72M	Sell	22,273 -960	-4%	-$77.4K	﹤0.01%	1527
2021 Q2	$1.87M	Sell	23,233 -79	-0.3%	-$6.27K	﹤0.01%	1470
2021 Q1	$1.84M	Sell	23,312 -3,640	-14%	-$284K	0.01%	1387
2020 Q4	$1.92M	Sell	26,952 -3,894	-13%	-$261K	0.01%	1261
2020 Q3	$1.97M	Buy	30,846 +200	+0.7%	+$13.1K	0.01%	1109
2020 Q2	$1.98M	Buy	30,646 +1,075	+4%	+$66.8K	0.01%	1035
2020 Q1	$1.63M	Sell	29,571 -1,370	-4%	-$83.4K	0.01%	992
2019 Q4	$2M	Sell	30,941 -3,087	-9%	-$188K	0.01%	1034
2019 Q3	$1.93M	Sell	34,028 -9,240	-21%	-$532K	0.01%	995
2019 Q2	$2.6M	Sell	43,268 -1,423	-3%	-$87.3K	0.01%	839
2019 Q1	$2.91M	Sell	44,691 -5,185	-10%	-$341K	0.01%	755
2018 Q4	$3.11M	Sell	49,876 -2,742	-5%	-$185K	0.02%	648
2018 Q3	$3.87M	Sell	52,618 -1,968	-4%	-$141K	0.02%	621
2018 Q2	$3.67M	Sell	54,586 -2,736	-5%	-$176K	0.02%	624
2018 Q1	$3.58M	Sell	57,322 -6,468	-10%	-$426K	0.02%	606
2017 Q4	$4.09M	Sell	63,790 -4,354	-6%	-$279K	0.02%	541
2017 Q3	$4.45M	Sell	68,144 -9,101	-12%	-$575K	0.03%	484
2017 Q2	$4.85M	Sell	77,245 -9,027	-10%	-$542K	0.03%	449
2017 Q1	$5.07M	Sell	86,272 -21,044	-20%	-$1.23M	0.03%	416
2016 Q4	$6.01M	Sell	107,316 -13,938	-11%	-$803K	0.04%	342
2016 Q3	$7.47M	Buy	121,254 +1,328	+1%	+$87K	0.06%	287
2016 Q2	$7.6M	Buy	119,926 +1,349	+1%	+$84.8K	0.06%	268
2016 Q1	$7.12M	Sell	118,577 -243	-0.2%	-$14.9K	0.06%	277
2015 Q4	$8.31M	Sell	118,820 -20,594	-15%	-$1.46M	0.08%	236
2015 Q3	$9.25M	Buy	139,414 +25,141	+22%	+$1.96M	0.1%	205
2015 Q2	$8.95M	Buy	114,273 +45,568	+66%	+$3.55M	0.09%	217
2015 Q1	$5.25M	Buy	68,705 +9,042	+15%	+$665K	0.05%	305
2014 Q4	$3.97M	Buy	59,663 +9,890	+20%	+$659K	0.04%	358
2014 Q3	$3.17M	Buy	49,773 +1,737	+4%	+$107K	0.04%	405
2014 Q2	$2.93M	Sell	48,036 -27,239	-36%	-$1.58M	0.04%	422
2014 Q1	$4.26M	Buy	75,275 +37,380	+99%	+$2.12M	0.06%	288
2013 Q4	$2.03M	Buy	37,895 +13,227	+54%	+$662K	0.03%	494
2013 Q3	$1.14M	Buy	24,668 +10,399	+73%	+$475K	0.02%	656
2013 Q2	$603K	Buy	+14,269	New	+$594K	0.01%	936

Other funds holding PJP

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $145M AUM

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Diversified Enterprises Wilmington, Delaware $2.07B AUM 22.34% 1-Year Est. Return

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 33.48% 1-Year Est. Return

Commonwealth Equity Services's PJP Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Invesco Pharmaceuticals ETF (PJP) stake by 20% in Q2 2026, selling an estimated $219K and leaving 8,285 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Commonwealth Equity Services first reported a position in PJP in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.25M in Q3 2015. 42 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Commonwealth Equity Services held 8,285 shares of Invesco Pharmaceuticals ETF worth $981K as of Q2 2026.
Commonwealth Equity Services sold 2,020 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $219K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2727 holding.
Commonwealth Equity Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
Commonwealth Equity Services's Invesco Pharmaceuticals ETF position peaked at $9.25M in Q3 2015.
42 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.